Ticker Details
Tenaya Therapeutics, Inc.
IPO Date:	June 30, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$184.45M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.27 | 5.20%
Avg Daily Range (30 D):	$0.03 | 3.48%
Avg Daily Range (90 D):	$0.04 | 4.77%

Institutional Daily Volume
Avg Daily Volume:	1.49M
Avg Daily Volume (30 D):	2.94M
Avg Daily Volume (90 D):	4.01M

Trade Size
Avg Trade Size (Sh.):	319
Avg Trade Size (Sh.) (30 D):	448
Avg Trade Size (Sh.) (90 D):	465

Institutional Trades
Total Institutional Trades:	114
Avg Institutional Trade:	$1.6M
Avg Institutional Trade (30 D):	$.74M
Avg Institutional Trade (90 D):	$.69M
Avg Institutional Trade Volume:	.48M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.84M
Avg Closing Trade (30 D):	$.74M
Avg Closing Trade (90 D):	$.75M
Avg Closing Volume:	725.4K

News

Mar 5, 2026 @ 6:35 PM Tenaya Therapeutics Stock Jumps After New Alnylam ... Source: Vandana Singh

Nov 8, 2025 @ 4:25 PM Tenaya Therapeutics Presents Promising Interim Cli... Source: Tenaya Therapeutics

Aug 31, 2025 @ 2:15 PM Tenaya Therapeutics Presents Interim Data from MyC... Source: Tenaya Therapeutics

Mar 4, 2025 @ 3:55 PM 2025 Market Prospects of Adeno-Associated Virus Ve... Source: Researchandmarkets.Com

Jun 27, 2024 @ 9:00 PM Tenaya Therapeutics Announces Research Leadership ... Source: Tenaya Therapeutics, Inc.

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.46	$-.09	$-.11
Diluted EPS	$-.46	$-.09	$-.11
Revenue	$.23M	$.23M	$M
Gross Profit
Net Income / Loss	$-83.01M	$-19.27M	$-20.18M
Operating Income / Loss	$-85.86M	$-20.07M	$-20.78M
Cost of Revenue
Net Cash Flow	$27.12M	$-19.66M	$44.24M
PE Ratio